These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19236383)

  • 1. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
    Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
    Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No increase of calcitonin gene-related peptide in jugular blood during migraine.
    Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
    Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide and size of the atrial septal defect in new-onset migraine after transcatheter closure: results of a preliminary study.
    Wei SH; Fan PC; Kuo PH; Chiou LC; Wang JK
    Headache; 2012 Jun; 52(6):985-92. PubMed ID: 22486257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
    Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
    Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
    Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
    Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
    Cady RK; Vause CV; Ho TW; Bigal ME; Durham PL
    Headache; 2009 Oct; 49(9):1258-66. PubMed ID: 19788468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack.
    Juhasz G; Zsombok T; Jakab B; Nemeth J; Szolcsanyi J; Bagdy G
    Cephalalgia; 2005 Mar; 25(3):179-83. PubMed ID: 15689192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial progenitor cells: a new key for endothelial dysfunction in migraine.
    Rodríguez-Osorio X; Sobrino T; Brea D; Martínez F; Castillo J; Leira R
    Neurology; 2012 Jul; 79(5):474-9. PubMed ID: 22815557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
    Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
    Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine levels in the jugular venous blood of migraine without aura patients during attacks.
    Sarchielli P; Alberti A; Vaianella L; Pierguidi L; Floridi A; Mazzotta G; Floridi A; Gallai V
    Headache; 2004; 44(10):961-8. PubMed ID: 15546258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
    Bellamy JL; Cady RK; Durham PL
    Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin gene-related peptide in cervicogenic headache.
    Frese A; Schilgen M; Edvinsson L; Frandsen E; Evers S
    Cephalalgia; 2005 Sep; 25(9):700-3. PubMed ID: 16109051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.
    Fusayasu E; Kowa H; Takeshima T; Nakaso K; Nakashima K
    Pain; 2007 Apr; 128(3):209-214. PubMed ID: 17123735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cytokine levels in migraineurs and controls.
    Perini F; D'Andrea G; Galloni E; Pignatelli F; Billo G; Alba S; Bussone G; Toso V
    Headache; 2005; 45(7):926-31. PubMed ID: 15985111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
    Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
    J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interictal amylin levels in chronic migraine patients: A case-control study.
    Irimia P; Martínez-Valbuena I; Mínguez-Olaondo A; Domínguez-Vivero C; Sánchez-Arias JA; Martínez-Vila E; Luquin MR; Leira R
    Cephalalgia; 2021 Apr; 41(5):604-612. PubMed ID: 33269952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks.
    Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
    Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
    Ramón C; Cernuda-Morollón E; Pascual J
    Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype.
    Hansen JM; Thomsen LL; Olesen J; Ashina M
    Neurology; 2008 Sep; 71(11):841-7. PubMed ID: 18779512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack?
    Vural S; Albayrak L
    J Recept Signal Transduct Res; 2022 Dec; 42(6):562-566. PubMed ID: 35895308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.